The Latest Headlines at Markets Daily
Salem Media Group (NASDAQ:SALM) Earns Hold Rating from Analysts at StockNews.com
StockNews.com initiated coverage on shares of Salem Media Group (NASDAQ:SALM – Free Report) in a research note published on Wednesday. The firm issued a hold rating on the stock. Salem Media Group Stock Performance Shares of... More of this article »
Pulmatrix (NASDAQ:PULM) Earns Hold Rating from Analysts at StockNews.com
StockNews.com initiated coverage on shares of Pulmatrix (NASDAQ:PULM – Free Report) in a research report report published on Wednesday. The firm issued a hold rating on the biotechnology company’s stock. Pulmatrix Stock... More of this article »
RF Industries (NASDAQ:RFIL) Research Coverage Started at StockNews.com
StockNews.com assumed coverage on shares of RF Industries (NASDAQ:RFIL – Free Report) in a research note released on Wednesday. The firm issued a hold rating on the electronics maker’s stock. Separately, B. Riley reduced... More of this article »
Evolent Health, Inc. (NYSE:EVH) Receives Consensus Recommendation of “Moderate Buy” from Brokerages
Shares of Evolent Health, Inc. (NYSE:EVH – Get Free Report) have received a consensus recommendation of “Moderate Buy” from the twelve analysts that are presently covering the company, Marketbeat.com reports. One... More of this article »
Amazon.com (NASDAQ:AMZN) Price Target Raised to $235.00
Amazon.com (NASDAQ:AMZN) had its price target lifted by Citigroup from $215.00 to $235.00 in a report issued on Wednesday, Benzinga reports. The firm currently has a buy rating on the e-commerce giant’s stock. AMZN has been the... More of this article »
Genelux Co. (NASDAQ:GNLX) Major Shareholder Sells $50,588.43 in Stock
Genelux Co. (NASDAQ:GNLX – Get Free Report) major shareholder Aladar Szalay sold 14,331 shares of the stock in a transaction dated Monday, April 22nd. The stock was sold at an average price of $3.53, for a total transaction of... More of this article »
Collegium Pharmaceutical (NASDAQ:COLL) Stock Rating Upgraded by StockNews.com
StockNews.com upgraded shares of Collegium Pharmaceutical (NASDAQ:COLL – Free Report) from a buy rating to a strong-buy rating in a research note issued to investors on Tuesday. A number of other research analysts also recently... More of this article »
Global Partners (NYSE:GLP) Cut to “Hold” at StockNews.com
StockNews.com downgraded shares of Global Partners (NYSE:GLP – Free Report) from a buy rating to a hold rating in a report released on Tuesday morning. Separately, Stifel Nicolaus upped their price target on shares of Global... More of this article »
JetBlue Airways (NASDAQ:JBLU) Price Target Lowered to $6.00 at TD Cowen
JetBlue Airways (NASDAQ:JBLU – Free Report) had its target price cut by TD Cowen from $7.00 to $6.00 in a research note issued to investors on Tuesday morning, Marketbeat Ratings reports. They currently have a hold rating on... More of this article »
Bally’s (NYSE:BALY) Given New $16.00 Price Target at Truist Financial
Bally’s (NYSE:BALY – Free Report) had its price objective hoisted by Truist Financial from $14.00 to $16.00 in a research report released on Tuesday morning, Benzinga reports. Truist Financial currently has a buy rating... More of this article »
Truist Financial Cuts Everi (NYSE:EVRI) Price Target to $11.00
Everi (NYSE:EVRI – Free Report) had its price objective lowered by Truist Financial from $13.00 to $11.00 in a report released on Tuesday morning, Benzinga reports. The brokerage currently has a hold rating on the credit services... More of this article »
Immunocore (NASDAQ:IMCR) Receives Buy Rating from Guggenheim
Guggenheim restated their buy rating on shares of Immunocore (NASDAQ:IMCR – Free Report) in a report issued on Tuesday, Benzinga reports. The firm currently has a $92.00 price target on the stock. Other research analysts have... More of this article »
Stifel Nicolaus Increases Devon Energy (NYSE:DVN) Price Target to $66.00
Devon Energy (NYSE:DVN – Free Report) had its price objective upped by Stifel Nicolaus from $65.00 to $66.00 in a report published on Tuesday morning, Benzinga reports. The brokerage currently has a buy rating on the energy company’s... More of this article »